Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qiulan Ding

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Thrombosis Research|February 22, 2024
A noncanonical splicing variant c.875-5 T > G in von Willebrand factor causes in-frame exon skipping and type 2A von Willebrand diseaseQian Liang, Ziqi Zhang, Biying Ding, et al.
International Journal of Clinical and Experimental Medicine|August 27, 2015
A novel factor X gene mutation Val (GTC) 384Ala (GCC) in a Chinese family resulting in congenital factor X deficiencyYanming Wang, Junjie Ma, Xinguang Liu, et al.
Thrombosis Research|December 30, 2023
A novel GATA1 variant p.G229D causing the defect of procoagulant platelet formationBiying Ding, Yinqi Mao, Yang Li, et al.
Thrombosis Research|April 17, 2026
Pseudoexon inclusion induced by three deep intronic variants in hemophilia B and correction achieved through an antisense oligonucleotide-based strategyGuangming Chen, Jialu Zhang, Liya Lin, et al.
Chemical Biology & Drug Design|May 21, 2019
An unexpected dynamic binding mode between coagulation factor X and Rivaroxaban reveals importance of flexibility in drug bindingSi-Ying Qu, Qin Xu, Wenman Wu, et al.
Human Mutation|December 9, 2021
Unraveling the molecular basis underlying nine putative splice site variants of von Willebrand factorQian Liang, Xiaoyi Lin, Xi Wu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 17, 2025
Correction of VWF multimerization in type 2A/IIC von Willebrand disease by exogenous VWF propeptide supplementationZiqi Zhang, Qian Liang, Xiaoqian Xu, et al.
Haematologica|July 10, 2025
Perioperative management of total hip arthroplasty in hemophilia A following gene therapyYanyan Shao, Chuanlong Wu, Wei Liu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 27, 2019
Prothrombin Arg541Trp Mutation Leads to Defective PC (Protein C) Pathway Activation and Constitutes a Novel Genetic Risk Factor for Venous ThrombosisXi Wu, Jing Dai, Xiaoqian Xu, et al.
Journal of Thrombosis and Haemostasis : JTH|May 8, 2025
A comprehensive study of antithrombin deficiency in a large cohort of Chinese thrombophilia pedigrees: uncovering 4 SERPINC1 pathogenic variants merely impaired progressive activitiesChangming Chen, Xi Wu, Lei Li, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Thrombosis Research|February 22, 2024
A noncanonical splicing variant c.875-5 T > G in von Willebrand factor causes in-frame exon skipping and type 2A von Willebrand diseaseQian Liang, Ziqi Zhang, Biying Ding, et al.
International Journal of Clinical and Experimental Medicine|August 27, 2015
A novel factor X gene mutation Val (GTC) 384Ala (GCC) in a Chinese family resulting in congenital factor X deficiencyYanming Wang, Junjie Ma, Xinguang Liu, et al.
Thrombosis Research|December 30, 2023
A novel GATA1 variant p.G229D causing the defect of procoagulant platelet formationBiying Ding, Yinqi Mao, Yang Li, et al.
Thrombosis Research|April 17, 2026
Pseudoexon inclusion induced by three deep intronic variants in hemophilia B and correction achieved through an antisense oligonucleotide-based strategyGuangming Chen, Jialu Zhang, Liya Lin, et al.
Chemical Biology & Drug Design|May 21, 2019
An unexpected dynamic binding mode between coagulation factor X and Rivaroxaban reveals importance of flexibility in drug bindingSi-Ying Qu, Qin Xu, Wenman Wu, et al.
Human Mutation|December 9, 2021
Unraveling the molecular basis underlying nine putative splice site variants of von Willebrand factorQian Liang, Xiaoyi Lin, Xi Wu, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 17, 2025
Correction of VWF multimerization in type 2A/IIC von Willebrand disease by exogenous VWF propeptide supplementationZiqi Zhang, Qian Liang, Xiaoqian Xu, et al.
Haematologica|July 10, 2025
Perioperative management of total hip arthroplasty in hemophilia A following gene therapyYanyan Shao, Chuanlong Wu, Wei Liu, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|December 27, 2019
Prothrombin Arg541Trp Mutation Leads to Defective PC (Protein C) Pathway Activation and Constitutes a Novel Genetic Risk Factor for Venous ThrombosisXi Wu, Jing Dai, Xiaoqian Xu, et al.
Journal of Thrombosis and Haemostasis : JTH|May 8, 2025
A comprehensive study of antithrombin deficiency in a large cohort of Chinese thrombophilia pedigrees: uncovering 4 SERPINC1 pathogenic variants merely impaired progressive activitiesChangming Chen, Xi Wu, Lei Li, et al.
Pageof 10